In a recent contribution to this journal, Patrick Tully criticizes my view that the doctrine of double effect does not prohibit a pharmaceutical company from selling a drug that has potentially fatal side-effects and that does not treat a life-threatening condition. Tully alleges my account is too permissive and makes the doctrine irrelevant to decisions about selling harmful products. In the following paper, I respond to Tully’s objections and show that he misinterprets my position and misstates some elements of the (...) doctrine of double effect. I also show how the doctrine constrains some decisions about marketing drugs with potentially fatal side-effects. (shrink)

Both the spirituality in organizations and managerial issues have been addressed through different religion-based beliefs. In this article, one intends to enlarge it through the perspective of the Spiritist Doctrine (SD). Thus, it reviews the SD literature, as well as spirituality in organizations theory to find common views. In addition, it (1) argued that SD tenets, codified by Allan Kardec, also bring helpful contributions to work settings that differ from the traditional religion approaches and (2) discussed its implications to managers' (...) spiritual development. It is posited that the SD tenets, while building on and expanding Jesus Christ's teachings, disclose us some severe implications related to our future. In a broader view, SD tenets provide important warnings that encompass people work lives as well. Finally, we depict a framework that embraces corporate life coupled with some factors that may likely build and enhances one's spiritual progress, the potential spiritual rewards derived from these factors, and the loci where the rewards are enjoyed. (shrink)

The 20th century produced overwhelming advances in biomedicine with the 1990s introducing 148,000 patents as part of the mapping and sequencing of the human genome. Bioethical realities and debates of prenatal genetic testing, new reproductive technologies, stem cell research, human cloning and DNA data banks have obscured the less provocative public and social issues of gun control, immunization, employee leave programs to assist care for dying relatives, emergency room use as primary care sites by the uninsured, and medical care provision (...) to the homeless. With the events of September 11, the focus has shifted to bioterrorism: an international and global concern that portends broad environmental consequences while requiring a local, community response of which the business enterprise is a part. The tension that results from a required local and global response to bioterrorism and biotechnology by the business community forms a dialectic and provides a venue for addressing business ethics in an international forum. This paper explores the relationship of events and its meaning for business. Part I provides the background of biotechnology and bioterrorism and how the two form a dialectic reality that shapes ethical debate. Part II presents provocations and questions for an emerging ethic based on the integrative response from the public health, medical, business and religious communities. Four areas for business contribution in shaping emerging ethics in the age of biotechnology—bioterrorism are suggested. (shrink)